Trial site
The Valley Hospital
- 11running trials
- 12closed trials
The trials here
What the 23 trials at this site are about, from their registry records.
- Conditions
- Atrial fibrillation6 trials
- Coronary artery disease6 trials
- Aortic stenosis4 trials
- Stroke4 trials
- Lung cancer2 trials
- Familial hypercholesterolaemia1 trial
- Heart failure1 trial
- High blood pressure1 trial
- Hypertrophic cardiomyopathy1 trial
- Obesity1 trial
- Prostate cancer1 trial
- Thymoma and thymic carcinoma1 trial
- Phase
- Phase 35 trials
- Phase 43 trials
- Phase 11 trial
- Phase 21 trial
- Status
- Active, not recruiting9 trials
- Completed7 trials
- Withdrawn3 trials
- Recruiting2 trials
- Terminated2 trials
- Lead sponsor
- Edwards Lifesciences3 trials
- Novartis Pharmaceuticals3 trials
- Adagio Medical1 trial
- American Heart Association1 trial
- Boston Scientific Corporation1 trial
- and 14 more
Running trials
Active, not recruiting
Active, not recruiting
Advancing Cath Lab Results With FFRangio Coronary Physiology Assessment
Recruiting
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Active, not recruiting
Recruiting
ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve
Active, not recruiting
Recruiting
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
Active, not recruiting
Active, not recruiting
Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
Active, not recruiting
Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Aortic stenosis1 recruiting
- Coronary artery disease1 recruiting
Closed trials
Recruiting
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
Recruiting
Withdrawn
Tipifarnib and Osimertinib in EGFR-mutated Non-Small Cell Lung Cancer
Completed
Completed
Terminated
Completed
Completed
Completed
Terminated
Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation
Completed
Completed
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
Site data: ClinicalTrials.govUpdated 13 Nov 2026